Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09SXR
|
|||
Former ID |
DIB009241
|
|||
Drug Name |
KRH-102053
|
|||
Synonyms |
PHD2 activators (hypoxic cancer), Chonbuk National University/SK Chemicals
Click to Show/Hide
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
Company |
Chonbuk National University
|
|||
Structure |
Download2D MOL |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | HIF-prolyl hydroxylase 2 (HPH-2) | Target Info | Activator | [1] |
KEGG Pathway | HIF-1 signaling pathway | |||
Pathways in cancer | ||||
Renal cell carcinoma | ||||
Panther Pathway | Hypoxia response via HIF activation | |||
Pathway Interaction Database | HIF-2-alpha transcription factor network | |||
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha | ||||
HIF-1-alpha transcription factor network | ||||
Reactome | Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2833). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.